1. 中华医学会结核病分会NTM专委会副主任委员

2. 中华医学会结核病分会科学研究专委会委员

3. 中国防痨协会基础研究专委会常委

4. 中国防痨协会生物样本与数据资源专委会常委

5. 四川省医学会结核病分会常委

主要研究方向：

1. 分枝杆菌外膜通道蛋白、脂蛋白和脂质的生理功能、转运组装过程和调控网络。

2. 关键外膜因子调控宿主免疫的分子机制，筛选能用于抗结核疫苗开发的外膜抗原。

3. 能高效通过分枝杆菌外膜、能缩短疗程的抗结核小分子药物筛选。

4. 肺部微生态研究和肺癌的微生物疗法开发。

主持或参与的科研项目：

1、国家自然科学基金优秀青年基金（海外），结核分枝杆菌外膜和能缩短疗程的抗结核新药研发，17-王晴岚， 2022.09-2025.09, 项目负责人。

2、国家自然科学基金面上项目，结核分枝杆菌PE/PPE蛋白介导的耐药机制研究，82272375， 2023.01-2026.12，项目负责人。

3、四川省“天府峨眉”计划项目，抗结核创新药物研发，王晴岚， 2023.01-2025.12，项目负责人。

4、四川省自然科学基金面上项目，结核分枝杆菌PPE51蛋白介导的细菌耐贝达喹啉机制研究，2025ZNSFSC0675，2025.1-2026.12，项目负责人。

5、国家科技重大专项，呼吸道微生态失衡在慢阻肺病发生发展中的作用机制研究，2024ZD0528400, 2025.1-2028.12，课题负责人。

代表性论文：

1. Linai Li^#, Yuxiang Hu^#, Dan Wang, Xin Li, Shengjuan Bao, Taibing Deng, Qinglan Wang*; A CRISPR/Cas9-based system using dual-sgRNAs for efficient gene deletion in Mycobacterium abscessus; Front. Microbiol., 09 July 2025.

2. Zhijing Zhang^#, Le Dong^#, Xin Li, Taibing Deng, Qinglan Wang*; The PE/PPE family proteins of Mycobacterium tuberculosis: evolution, function, and prospects for tuberculosis control; Front. Immunol., 17 June 2025.

3. Ming-Gui Wang, Mei Liu, Dan Wang, Danni Yang, Yiwei Zeng, Yuanbo Lan, Qinglan Wang*; Engineered bacteria for cancer therapy: advancements, challenges, and future directions; Chinese Medical Journal, 2025 Accepted.

4. Daoyan Tanga^#, Minggui Wang^#, Dan Wang, Danni Yang, Yi Cai, Tao Luo, Jianqing He*, Qinglan Wang*; Ultra-high field strength electroporation enables efficient DNA transformation and genome editing in nontuberculous mycobacteria; Microbiology Spectrum, 2025 Accepted.

5. Fang C, He X, Tang F, Wang Z, Pan C, Zhang Q, Wu J, Wang Q*, Liu D*, Zhang Y*; Where lung cancer and tuberculosis intersect: recent advances; Front Immunol. 2025 Apr 2;16:1561719.

6. Qin Y, Wang Q*, Shi J; Immune checkpoint modulating T cells and NK cells response to Mycobacterium tuberculosis infection; Microbiol Res. 2023 Aug;273:127393.

7. Lyu M, Zhou J, Zhou Y, Chong W, Xu W, Lai H, Niu L, Hai Y, Yao X, Gong S, Wang Q, Chen Y, Wang Y, Chen L, Zengwanggema, Zeng J, Wang C, Ying B; From tuberculosis bedside to bench: UBE2B splicing as a potential biomarker and its regulatory mechanism; Signal Transduct Target Ther. 2023 Feb 24;8(1):82.

8. Wang Q, Yang D, Zuo Y, Wang D, Li W; Emerging roles of circular RNAs in tuberculosis; Front Immunol. 2022 Sep 20;13:995701.

9. Green SR, Davis SH, Damerow S, Engelhart CA, Mathieson M, Baragaña B, Robinson DA, Tamjar J, Dawson A, Tamaki FK, Buchanan KI, Post J, Dowers K, Shepherd SM, Jansen C, Zuccotto F, Gilbert IH, Epemolu O, Riley J, Stojanovski L, Osuna-Cabello M, Pérez-Herrán E, Rebollo MJ, Guijarro López L, Casado Castro P, Camino I, Kim HC, Bean JM, Nahiyaan N, Rhee KY, Wang Q, Tan VY, Boshoff HIM, Converse PJ, Li SY, Chang YS, Fotouhi N, Upton AM, Nuermberger EL, Schnappinger D, Read KD, Encinas L, Bates RH, Wyatt PG, Cleghorn LAT; Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs; Nat Commun. 2022 Oct 11;13(1):5992.

10. Qinglan Wang, Helena I. M. Boshoff; Determining Minimum Inhibitory Concentrations in Liquid Cultures or on Solid Medium; Methods in Molecular Biology, 2021,2314:595-609. (Chapter)

11. Qinglan Wang, Helena I. M. Boshoff, Justin R. Harrison, Thomas Ioerger, Peter C. Ray, Simon R. Green, Paul G. Wyatt, Clifton E. Barry III; PE/PPE proteins mediate nutrient transport across the outer membrane of Mycobacterium tuberculosis; Science, 2020 Mar; 367(6482):1147-1151.

12. Qingfei Zheng^#, Qinglan Wang^#, Shoufeng Wang, Jiequn Wu, Qian Gao, and Wen Liu; Thiopeptides Induce Host Autophagy as the Primary Mode of Action against Intracellular Pathogen; Cell Chemical Biology, 2015 Aug 20;22(8):1002-7. (共同第一作者). 

13. Qinglan Wang, Lin Zhu, Victoria Jones, Chuan Wang, Yifei Hua, Xujun Shi, Xia Feng, Mary Jackson, Chen Niu and Qian Gao; CpsA, a LytR-CpsA-Psr Family Protein in Mycobacterium marinum, is Required for Cell Wall Integrity and Virulence; Infection and Immunity, 2015 Jul;83(7):2844-54.